Cutera
Founded Year
1998Stage
Loan | IPOTotal Raised
$14.95MMarket Cap
0.33BStock Price
16.81Missing: Cutera's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Cutera's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Cutera
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Cutera is included in 1 Expert Collection, including Medical Devices.
Medical Devices
3,088 items
Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)
Cutera Patents
Cutera has filed 41 patents.
The 3 most popular patent topics include:
- Laser applications
- Laser science
- Spectroscopy
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/22/2020 | 8/2/2022 | Spectroscopy, Laser science, Laser applications, Nonlinear optics, Laser medicine | Grant |
Application Date | 5/22/2020 |
|---|---|
Grant Date | 8/2/2022 |
Title | |
Related Topics | Spectroscopy, Laser science, Laser applications, Nonlinear optics, Laser medicine |
Status | Grant |
Latest Cutera News
Jun 1, 2023
News provided by Share this article Share this article CEDARHURST, N.Y., May 31, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Cutera, Inc. (NasdaqGS: CUTR), if they purchased the Company's shares between February 17, 2021 and May 9, 2023, inclusive (the "Class Period"). Shareholders have until July 24, 2023 to file lead plaintiff applications in the securities class action lawsuit. Shareholders are encouraged to contact us at https://kclasslaw.com/cases/securities/nasdaqgs-cutr/ , by calling toll-free at 1-833-835-1495 or by email ( [email protected] ). Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Cedarhurst, NY 11516 Also from this source PRN Top Stories Newsletters Enter Your Email By signing up you agree to receive content from us. Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice . You can withdraw your consent at any time in the footer of every email you'll receive.Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten. Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice . Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen.En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part. Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice . Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu.Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN . Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.
Cutera Frequently Asked Questions (FAQ)
When was Cutera founded?
Cutera was founded in 1998.
Where is Cutera's headquarters?
Cutera's headquarters is located at 3240 Bayshore Boulevard, Brisbane.
What is Cutera's latest funding round?
Cutera's latest funding round is Loan.
How much did Cutera raise?
Cutera raised a total of $14.95M.
Who are the investors of Cutera?
Investors of Cutera include Paycheck Protection Program, MedVenture Associates and Alta Partners.
Who are Cutera's competitors?
Competitors of Cutera include Wright Medical Group, Paragon Medical, Spectranetics, Tricol Biomedical, Ulthera and 16 more.
Compare Cutera to Competitors
Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.
Nephrologix Inc. is a private company that develops, manufactures and markets peritoneal dialysis (PD) systems.
Osteosymbionics is a medical device company. It had developed the Osteosymbionics Patient Specific Cranial Implant.We work very hard to make great implants that help people. Computer tools are effective, but sometimes the eyes and hands of a sculptor are what makes the difference in a complex reconstructive case. The blending of artistry and engineering contributes to our ability to make almost anything that a surgeon needs to help a patient.
Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures. The Sniper balloon occlusion microcatheter aims to set a new standard for precise embolic delivery and target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. The company was founded in 2013 and is based in Sunnyvale, California.
TrueVision Systems, dba TrueVisions 3D Surgical, provides digital 3D visualization and guidance for microsurgery. The company has developed an intelligent, real-time, 3D surgical visualization and computer-aided guidance platform. TrueVision combines 3D visualization and guidance software applications focused on improving accuracy, efficiency, and outcomes for both surgeons and patients. The company is developing 3D guidance applications for microsurgery to improve surgical efficiencies and patient outcomes. The Refractive Cataract Toolset is a computer-aided software for astigmatic correction and advanced IOL positioning.
ContourMed is a manufacturer of custom and non-custom breast products. Harnessing laser scanning and 3-D CAD/CAM technology with its patented handcrafted processes, ContourMed aims to create the most life-like look and feel custom breast prostheses available in the world.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.